PK-CIA-06, NCT01280240: Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia |
|
|
| Completed | 1 | 11 | US | Monofer(R), iron isomaltoside 1000 | Pharmacosmos A/S | Patients With Chemotherapy Induced Anemia (CIA) | 09/12 | 11/12 | | |
NCT03013439: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) |
|
|
| Completed | 1 | 24 | Japan | Iron Isomaltoside, Monofer | Pharmacosmos A/S | Anemia, Deficiency Diseases, Anemia, Iron Deficiency, Hematologic Disease, Iron Metabolism Disorders | 06/17 | 06/17 | | |
